209 related articles for article (PubMed ID: 12359450)
1. Construction and characterization of E1-minus replication-defective adenovirus vectors that express E3 proteins from the E1 region.
Toth K; Kuppuswamy M; Doronin K; Doronina O; Lichtenstein D; Tollefson A; Wold W
Virology; 2002 Sep; 301(1):99-108. PubMed ID: 12359450
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of TRAIL-induced apoptosis and forced internalization of TRAIL receptor 1 by adenovirus proteins.
Tollefson AE; Toth K; Doronin K; Kuppuswamy M; Doronina OA; Lichtenstein DL; Hermiston TW; Smith CA; Wold WS
J Virol; 2001 Oct; 75(19):8875-87. PubMed ID: 11533151
[TBL] [Abstract][Full Text] [Related]
3. Distinct domains in the adenovirus E3 RIDalpha protein are required for degradation of Fas and the epidermal growth factor receptor.
Zanardi TA; Yei S; Lichtenstein DL; Tollefson AE; Wold WS
J Virol; 2003 Nov; 77(21):11685-96. PubMed ID: 14557654
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus RIDbeta subunit contains a tyrosine residue that is critical for RID-mediated receptor internalization and inhibition of Fas- and TRAIL-induced apoptosis.
Lichtenstein DL; Krajcsi P; Esteban DJ; Tollefson AE; Wold WS
J Virol; 2002 Nov; 76(22):11329-42. PubMed ID: 12388693
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus E3-6.7K protein is required in conjunction with the E3-RID protein complex for the internalization and degradation of TRAIL receptor 2.
Lichtenstein DL; Doronin K; Toth K; Kuppuswamy M; Wold WS; Tollefson AE
J Virol; 2004 Nov; 78(22):12297-307. PubMed ID: 15507617
[TBL] [Abstract][Full Text] [Related]
6. Mechanism for removal of tumor necrosis factor receptor 1 from the cell surface by the adenovirus RIDalpha/beta complex.
Chin YR; Horwitz MS
J Virol; 2005 Nov; 79(21):13606-17. PubMed ID: 16227281
[TBL] [Abstract][Full Text] [Related]
7. The adenovirus E3/10.4K-14.5K proteins down-modulate the apoptosis receptor Fas/Apo-1 by inducing its internalization.
Elsing A; Burgert HG
Proc Natl Acad Sci U S A; 1998 Aug; 95(17):10072-7. PubMed ID: 9707602
[TBL] [Abstract][Full Text] [Related]
8. The adenovirus E3-14.7K protein and the E3-10.4K/14.5K complex of proteins, which independently inhibit tumor necrosis factor (TNF)-induced apoptosis, also independently inhibit TNF-induced release of arachidonic acid.
Krajcsi P; Dimitrov T; Hermiston TW; Tollefson AE; Ranheim TS; Vande Pol SB; Stephenson AH; Wold WS
J Virol; 1996 Aug; 70(8):4904-13. PubMed ID: 8763993
[TBL] [Abstract][Full Text] [Related]
9. Constitutive expression of the adenovirus E3-14.7K protein does not prolong adenovirus vector DNA persistence but protects mice against lipopolysaccharide-induced acute hepatitis.
Gantzer M; Spitz E; Accard N; Rooke R
Hum Gene Ther; 2002 May; 13(8):921-33. PubMed ID: 12031125
[TBL] [Abstract][Full Text] [Related]
10. Production and characterization of improved adenovirus vectors with the E1, E2b, and E3 genes deleted.
Amalfitano A; Hauser MA; Hu H; Serra D; Begy CR; Chamberlain JS
J Virol; 1998 Feb; 72(2):926-33. PubMed ID: 9444984
[TBL] [Abstract][Full Text] [Related]
11. Functions and mechanisms of action of the adenovirus E3 proteins.
Lichtenstein DL; Toth K; Doronin K; Tollefson AE; Wold WS
Int Rev Immunol; 2004; 23(1-2):75-111. PubMed ID: 14690856
[TBL] [Abstract][Full Text] [Related]
12. Protease-deleted adenovirus vectors and complementing cell lines: potential applications of single-round replication mutants for vaccination and gene therapy.
Oualikene W; Lamoureux L; Weber JM; Massie B
Hum Gene Ther; 2000 Jun; 11(9):1341-53. PubMed ID: 10890743
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus E3-10.4K/14.5K protein complex inhibits tumor necrosis factor-induced translocation of cytosolic phospholipase A2 to membranes.
Dimitrov T; Krajcsi P; Hermiston TW; Tollefson AE; Hannink M; Wold WS
J Virol; 1997 Apr; 71(4):2830-7. PubMed ID: 9060638
[TBL] [Abstract][Full Text] [Related]
14. The adenovirus E3-10.4K/14.5K complex mediates loss of cell surface Fas (CD95) and resistance to Fas-induced apoptosis.
Shisler J; Yang C; Walter B; Ware CF; Gooding LR
J Virol; 1997 Nov; 71(11):8299-306. PubMed ID: 9343182
[TBL] [Abstract][Full Text] [Related]
15. The 10,400- and 14,500-dalton proteins encoded by region E3 of adenovirus function together to protect many but not all mouse cell lines against lysis by tumor necrosis factor.
Gooding LR; Ranheim TS; Tollefson AE; Aquino L; Duerksen-Hughes P; Horton TM; Wold WS
J Virol; 1991 Aug; 65(8):4114-23. PubMed ID: 1830111
[TBL] [Abstract][Full Text] [Related]
16. Lung-specific expression of adenovirus E3-14.7K in transgenic mice attenuates adenoviral vector-mediated lung inflammation and enhances transgene expression.
Harrod KS; Hermiston TW; Trapnell BC; Wold WS; Whitsett JA
Hum Gene Ther; 1998 Sep; 9(13):1885-98. PubMed ID: 9741427
[TBL] [Abstract][Full Text] [Related]
17. Development of cell lines capable of complementing E1, E4, and protein IX defective adenovirus type 5 mutants.
Krougliak V; Graham FL
Hum Gene Ther; 1995 Dec; 6(12):1575-86. PubMed ID: 8664382
[TBL] [Abstract][Full Text] [Related]
18. An adenovirus type 5 (Ad5) amplicon-based packaging cell line for production of high-capacity helper-independent deltaE1-E2-E3-E4 Ad5 vectors.
Catalucci D; Sporeno E; Cirillo A; Ciliberto G; Nicosia A; Colloca S
J Virol; 2005 May; 79(10):6400-9. PubMed ID: 15858023
[TBL] [Abstract][Full Text] [Related]
19. Subversion of host defense mechanisms by adenoviruses.
Burgert HG; Ruzsics Z; Obermeier S; Hilgendorf A; Windheim M; Elsing A
Curr Top Microbiol Immunol; 2002; 269():273-318. PubMed ID: 12224514
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus E3-6.7K maintains calcium homeostasis and prevents apoptosis and arachidonic acid release.
Moise AR; Grant JR; Vitalis TZ; Jefferies WA
J Virol; 2002 Feb; 76(4):1578-87. PubMed ID: 11799152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
